Revenue Disaggregated Revenue by Product Line (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)
Disaggregation of Revenue [Line Items]
Revenues	$ 566,655	$ 568,649
% Revenue to Medline	0.17	0.15
Infusion Consumables [Member]
Disaggregation of Revenue [Line Items]
Revenues	$ 244,039	$ 236,122
Infusion Systems [Member]
Disaggregation of Revenue [Line Items]
Revenues	157,338	161,713
Vital Care
Disaggregation of Revenue [Line Items]
Revenues	$ 165,278	$ 170,814